Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies

(2019) Jakob R. Passweg et al.   BONE MARROW TRANSPLANTATION

Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres

(2019) Hélène A. Poirel et al.   BONE MARROW TRANSPLANTATION

Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and Beyond

(2019) Marcelo C. Pasquini et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019

(2019) Rafael F. Duarte et al.   BONE MARROW TRANSPLANTATION

Integration of Publicly Reported Center Outcomes into Standards and Accreditation: The FACT Model

(2019) Charles F. LeMaistre et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report

(2018) Jakob R Passweg et al.   BONE MARROW TRANSPLANTATION

Benchmarking clinical outcomes and the immunocatabolic phenotype of chronic critical illness after sepsis in surgical intensive care unit patients

(2018) Julie A. Stortz et al.   Journal of Trauma and Acute Care Surgery

Benchmarking clinical outcomes and the immunocatabolic phenotype of chronic critical illness after sepsis in surgical intensive care unit patients

(2018) Julie A. Stortz et al.   Journal of Trauma and Acute Care Surgery

Benchmarking Cancer Centers: From Care Pathways to Integrated Practice Units

(2018) Anke Wind et al.   Journal of the National Comprehensive Cancer Network

Clarifying Stem-Cell Therapy’s Benefits and Risks

(2017) Peter W. Marks et al.   NEW ENGLAND JOURNAL OF MEDICINE

How to build an allogeneic hematopoietic cell transplant unit in 2016: Proposal for a practical framework

(2017) M. Crysandt et al.   Current Research in Translational Medicine

How to prevent relapse after allogeneic hematopoietic stem cell transplantation in patients with acute leukemia and myelodysplastic syndrome

(2017) N. Yafour et al.   Current Research in Translational Medicine

Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study

(2015) Alois Gratwohl et al.   EBioMedicine

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation

(2014) P. Armand et al.   BLOOD

Benchmarking clinical outcomes in elective colorectal cancer surgery: The interplay between institutional reoperation- and mortality rates

(2014) D. Henneman et al.   EJSO

Use of the quality management system "JACIE" and outcome after hematopoietic stem cell transplantation

(2014) A. Gratwohl et al.   HAEMATOLOGICA

Introduction of a Quality Management System and Outcome After Hematopoietic Stem-Cell Transplantation

(2011) Alois Gratwohl et al.   JOURNAL OF CLINICAL ONCOLOGY

Reducing the Risk for Transplantation-Related Mortality After Allogeneic Hematopoietic Cell Transplantation: How Much Progress Has Been Made?

(2011) John T. Horan et al.   JOURNAL OF CLINICAL ONCOLOGY

How and why should we benchmark clinical outcomes and quality of life for surgery in spinal metastases?

(2009) D. Choi et al.   BRITISH JOURNAL OF NEUROSURGERY